Annual FCF
-$108.55 M
+$2.89 M+2.59%
31 December 2023
Summary:
C4 Therapeutics annual free cash flow is currently -$108.55 million, with the most recent change of +$2.89 million (+2.59%) on 31 December 2023. During the last 3 years, it has fallen by -$40.65 million (-59.86%). CCCC annual FCF is now -300.03% below its all-time high of $54.27 million, reached on 31 December 2019.CCCC Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$24.12 M
-$18.95 M-366.45%
30 September 2024
Summary:
C4 Therapeutics quarterly free cash flow is currently -$24.12 million, with the most recent change of -$18.95 million (-366.45%) on 30 September 2024. Over the past year, it has increased by +$7.19 million (+22.96%). CCCC quarterly FCF is now -366.45% below its all-time high of -$5.17 million, reached on 30 June 2024.CCCC Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$71.58 M
+$7.19 M+9.12%
30 September 2024
Summary:
C4 Therapeutics TTM free cash flow is currently -$71.58 million, with the most recent change of +$7.19 million (+9.12%) on 30 September 2024. Over the past year, it has increased by +$43.42 million (+37.76%). CCCC TTM FCF is now -324.78% below its all-time high of -$16.85 million, reached on 31 March 2020.CCCC TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCCC Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +2.6% | +23.0% | +37.8% |
| 3 y3 years | -59.9% | -31.4% | +15.1% |
| 5 y5 years | -451.8% | - | - |
CCCC Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -59.9% | +2.6% | -366.4% | +28.5% | at high | +39.5% |
| 5 y | 5 years | -300.0% | +2.6% | -366.4% | +28.5% | -324.8% | +39.5% |
| alltime | all time | -300.0% | +2.6% | -366.4% | +28.5% | -324.8% | +39.5% |
C4 Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$24.12 M(+366.4%) | -$71.58 M(-9.1%) |
| June 2024 | - | -$5.17 M(-71.5%) | -$78.76 M(-15.3%) |
| Mar 2024 | - | -$18.12 M(-25.0%) | -$92.95 M(-14.4%) |
| Dec 2023 | -$108.55 M(-2.6%) | -$24.17 M(-22.8%) | -$108.55 M(-5.6%) |
| Sept 2023 | - | -$31.31 M(+61.7%) | -$115.00 M(-0.0%) |
| June 2023 | - | -$19.36 M(-42.6%) | -$115.02 M(-2.8%) |
| Mar 2023 | - | -$33.71 M(+10.1%) | -$118.38 M(+6.2%) |
| Dec 2022 | -$111.44 M | -$30.62 M(-2.3%) | -$111.44 M(+4.5%) |
| Sept 2022 | - | -$31.32 M(+37.8%) | -$106.60 M(+13.8%) |
| June 2022 | - | -$22.72 M(-15.1%) | -$93.63 M(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$26.77 M(+3.8%) | -$89.66 M(+1.6%) |
| Dec 2021 | -$88.24 M(+30.0%) | -$25.78 M(+40.4%) | -$88.24 M(+4.6%) |
| Sept 2021 | - | -$18.36 M(-2.1%) | -$84.35 M(+4.6%) |
| June 2021 | - | -$18.75 M(-26.1%) | -$80.67 M(+5.6%) |
| Mar 2021 | - | -$25.36 M(+15.9%) | -$76.40 M(+12.5%) |
| Dec 2020 | -$67.90 M(-225.1%) | -$21.88 M(+49.1%) | -$67.90 M(+47.6%) |
| Sept 2020 | - | -$14.68 M(+1.3%) | -$46.02 M(+46.8%) |
| June 2020 | - | -$14.48 M(-14.0%) | -$31.34 M(+86.0%) |
| Mar 2020 | - | -$16.85 M | -$16.85 M |
| Dec 2019 | $54.27 M(-375.9%) | - | - |
| Dec 2018 | -$19.67 M | - | - |
FAQ
- What is C4 Therapeutics annual free cash flow?
- What is the all time high annual FCF for C4 Therapeutics?
- What is C4 Therapeutics annual FCF year-on-year change?
- What is C4 Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for C4 Therapeutics?
- What is C4 Therapeutics quarterly FCF year-on-year change?
- What is C4 Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for C4 Therapeutics?
- What is C4 Therapeutics TTM FCF year-on-year change?
What is C4 Therapeutics annual free cash flow?
The current annual FCF of CCCC is -$108.55 M
What is the all time high annual FCF for C4 Therapeutics?
C4 Therapeutics all-time high annual free cash flow is $54.27 M
What is C4 Therapeutics annual FCF year-on-year change?
Over the past year, CCCC annual free cash flow has changed by +$2.89 M (+2.59%)
What is C4 Therapeutics quarterly free cash flow?
The current quarterly FCF of CCCC is -$24.12 M
What is the all time high quarterly FCF for C4 Therapeutics?
C4 Therapeutics all-time high quarterly free cash flow is -$5.17 M
What is C4 Therapeutics quarterly FCF year-on-year change?
Over the past year, CCCC quarterly free cash flow has changed by +$7.19 M (+22.96%)
What is C4 Therapeutics TTM free cash flow?
The current TTM FCF of CCCC is -$71.58 M
What is the all time high TTM FCF for C4 Therapeutics?
C4 Therapeutics all-time high TTM free cash flow is -$16.85 M
What is C4 Therapeutics TTM FCF year-on-year change?
Over the past year, CCCC TTM free cash flow has changed by +$43.42 M (+37.76%)